Hematologic tumors are a group of malignant tumors originating from the hematopoietic system, mainly including leukemia, lymphoma, multiple myeloma, etc. Their incidence rate is increasing year by year, and their clinical manifestations and prognosis show a high degree of heterogeneity. Chengdu Hi-Tech Medical Association held the Hematology Branch Grassroots Tour Series Academic Activities and Hematology Tumor Post-ASH Tour on April 20, 2024 in Neijiang. Hematologic tumors have entered a new era of precision diagnosis and treatment, and the implementation of effective individualized treatment for patients will help to improve the remission rate and prolong the survival of patients. Famous experts from inside and outside the province will be invited to give academic presentations at this meeting.